Nuoli Si (诺力思)诺力思
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 赤峰万泽制药有限责任公司Chinese legal name: 赤峰万泽制药有限责任公司
主要成分Active Ingredients
- 甲苯磺酸托氟沙星Jiaben Huangsuan Tuofu Shaxing
药物知识说明
甲苯磺酸托氟沙星是一种在国家药监局注册认定的药品。标注生产企业为赤峰万泽制药有限责任公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：赤峰万泽制药有限责任公司Chinese legal name: 赤峰万泽制药有限责任公司、赤峰万泽制药有限责任公司Chinese legal name: 赤峰万泽制药有限责任公司、赤峰万泽制药有限责任公司Chinese legal name: 赤峰万泽制药有限责任公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 诺力思) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 赤峰万泽制药有限责任公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 赤峰万泽制药有限责任公司Chinese legal name: 赤峰万泽制药有限责任公司, 赤峰万泽制药有限责任公司Chinese legal name: 赤峰万泽制药有限责任公司, 赤峰万泽制药有限责任公司Chinese legal name: 赤峰万泽制药有限责任公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 诺力思Recorded Chinese name: 诺力思
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 0.15g*6片0.15 g × 6 tablets
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 赤峰万泽制药有限责任公司Chinese legal name: 赤峰万泽制药有限责任公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H19990165
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H19990165
Manufacturer
Chinese legal name: 赤峰万泽制药有限责任公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
0.15 g × 6 tablets
中文说明书原文Original Chinese source label
批准文号
国药准字H19990165
生产企业
赤峰万泽制药有限责任公司(国产)
适应症
本品由妥舒沙星沙敏感菌所致的各种感染，尿路感染，呼吸道感染，眼、耳、鼻、喉感染，妇科、生殖系统感染，腹部和肝、胆系统感染，骨和关节感染，皮肤感染，败血症和心内膜炎，脑膜炎。
用法用量
口服。 1.成人一日0.3～0.45g，分2次服用。 2.严重感染者一日0.6g，分2次服用。
不良反应
1.过敏反应 发热、呼吸困难、浮肿、间质性肺炎、光敏症、皮疹、皮肤瘙痒、嗜酸性细胞增多。
2.消化系统反应：恶心、呕吐、纳差、腹泻。
3.头痛、失眠、疲倦、痉挛、血小板减少。
4.偶可发生急性肾功能不全、粒细胞缺乏症、假膜性肠炎、低血糖、肝功能异常。
禁忌
1.对本品或喹诺酮类药物过敏者禁用。
2.孕妇、哺乳期妇女及18岁以下患者禁用。
注意事项
1.肾功能减退者慎用，若使用，应根据减退程度调整剂量。
2.肝功能不全者慎用，若使用，应注意监测肝功能，并根据减退程度调整剂量。
3.原有中枢神经系统疾患者，包括脑动脉硬化或癫痫病史者均应避免应用，有指征时权衡利弊应用。
4.喹诺酮类药物间存在交叉过敏反应，对任何一种喹诺酮类过敏者不宜使用本品。
5.本品可引起光敏反应，至少在光照后12小时才可接受治疗，治疗期间及治疗后数天内应避免过长时间暴露于明亮光照下。
6.出现光敏反应指征如皮肤灼热、发红、肿胀、水泡、皮疹、瘙痒、皮炎时应停止治疗。
贮藏
遮光，密封保存。
规格
0.15g*6片
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.